Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction

Obesity

Volumn 18, Issue 11, 2010, Pages 2204-2211

  Thompson, Olivia M ^a,b,c,d   Beresford, Shirley A A ^a,b   Kirk, Elizabeth A ^a   Bronner, Mary P ^e   Vaughan, Thomas L ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c Center for Human Nutrition   (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LEPTIN;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BLOOD; BODY MASS; CASE CONTROL STUDY; CYTOLOGY; FEMALE; HUMAN; LOWER ESOPHAGUS SPHINCTER; MALE; METAPLASIA; MIDDLE AGED; OBESITY; PATHOLOGY; RISK; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; WAIST HIP RATIO;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BODY MASS INDEX; CASE-CONTROL STUDIES; ESOPHAGOGASTRIC JUNCTION; FEMALE; HUMANS; LEPTIN; LOGISTIC MODELS; MALE; METAPLASIA; MIDDLE AGED; OBESITY; ODDS RATIO; RISK FACTORS; SEX FACTORS; WAIST-HIP RATIO; YOUNG ADULT;

EID: 78049267189     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.508     Document Type: Article

References (41)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24:2137-2150.
2. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005;97:142-146. (Pubitemid 40277094)
3. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002;11:235-256.
4. Vaughan TL. Esophagus. In: Franco El, Rohn TE (eds). Cancer Precursors: Epidemiology, Detection and Prevention. Springer-Verlag: New York, 2002. pp 96-116.
5. Engel LS, Chow WH, Vaughan TL et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003;95: 1404-1413.
6. Corley DA, Kubo A, Levin TR et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 2007;133:34-41; quiz 311.
7. Vaughan TL, Kristal AR, Blount PL et al. Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2002;11:745-752.
8. El-Serag HB, Kvapil P, Hacken-Bitar J, Kramer JR. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol 2005;100: 2151-2156.
9. Stein DJ, El-Serag HB, Kuczynski J, Kramer JR, Sampliner RE. The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther 2005;22:1005-1010.
10. Smith KJ, O'Brien SM, Smithers BM et al. Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2005;14:2481-2486.
11. Veugelers PJ, Porter GA, Guernsey DL, Casson AG. Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinoma. Dis Esophagus 2006;19:321-328.
12. Edelstein ZR, Farrow DC, Bronner MO, Rosen SN, Vaughan TL. Central adiposity and risk of Barrett's esophagus. Gastroenterology 2007;133:403-411.
13. Anderson LA, Watson RG, Murphy SJ et al. Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol 2007;13:1585-1594.
14. Ogunwobi O, Mutungi G, Beales ILP. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology 2006; 147:4505-4516.
15. Zhang Y, Proenca R, Maffei M et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425-432.
16. Considine R V, Sinha MK, Heiman ML et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
17. Kennedy A, Gettys TW, Watson P et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997;82:1293-1300.
18. Saad M F, Damani S, Gingerich RL et al. Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 1997;82:579-584.
19. Isidori AM, Strollo F, Morè M et al. Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab 2000;85: 1954-1962.
20. Monti V, Carlson JJ, Hunt SC, Adams TD. Relationship of ghrelin and leptin hormones with body mass index and waist circumference in a random sample of adults. J Am Diet Assoc 2006;106:822-8; quiz 829.
21. Beales IL, Ogunwobi OO. Leptin synergistically enhances the anti-apoptotic and growth-promoting effects of acid in OE33 oesophageal adenocarcinoma cells in culture. Mol Cell Endocrinol 2007;274:60-68.
22. Beales ILP, Ogunwobi OO, Cameron E et al. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study. BMC Cancer 2007;7:97.
23. Francois F, Roper J, Goodman A et al. The association of gastric leptin with oesophageal inflammation and metaplasia. Gut 2008;57:16-24.
24. Kendall BJ, Macdonald GA, Hayward NK et al.; Study of Digestive Health. Leptin and the risk of Barrett's oesophagus. Gut 2008;57:448-454.
25. Maeda K, Okubo K, Shimomura I et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 1996;221:286-289.
26. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83.
27. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935.
28. Gavrila A, Chan JL, Yiannakouris N et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 2003;88:4823-4831.
29. Ogunwobi OO, Beales IL. Globular adiponectin, acting via adiponectin receptor-1, inhibits leptin-stimulated oesophageal adenocarcinoma cell proliferation. Mol Cell Endocrinol 2008;285:43-50.
30. Rubenstein JH, Dahlkemper A, Kao JY et al. A pilot study of the association of low plasma adiponectin and Barrett's esophagus. Am J Gastroenterol 2008;103:1358-1364.
31. Rubenstein JH, Kao J Y, Madanick RD et al. Association of adiponectin multimers with Barrett's oesophagus. Gut 2009;58:1583-1589.
32. Mueller J, Werner M, Stolte M. Barrett's esophagus: histopathologic definitions and diagnostic criteria. World J Surg 2004;28:148-154.
33. Sharma P, Sampliner RE. Short segment Barrett's esophagus and intestinal metaplasia of the cardia\-it's not all symantics!!! Am J Gastroenterol 1998;93:2303-2304.
34. Spechler SJ. Short and ultrashort Barrett's esophagus\-what does it mean? Semin Gastrointest Dis 1997;8:59-67.
35. Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc 1978;73:40-46.
36. Robison LL, Daigle A. Control selection using random digit dialing for cases of childhood cancer. Am J Epidemiol 1984;120:164-166.
37. Sakkinen PA, Severson RK, Ross JA, Robison LL. Random-digit dialing for control selection in childhood cancer studies: the geographic proximity and demographics within matched sets. Am J Public Health 1995;85:555-557.
38. Voigt L F, Davis S, Koepsell TD. Do cases and controls matched on the first eight digits of their telephone number share geographic proximity and socioeconomic characteristics? Ann Epidemiol 2006;16:299-304.
39. Aneshensel CS. Elaborating an Explanation: Antecedent, Intervening, and Consequent Variables: Theory-based Data Analysis for the Social Sciences. Pine Forge Press: Thousand Oaks, CA, 2002, pp 158-190.
40. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006;207:12-22.
41. Kelesidis I, Kelesidis T, Mantzoros CS. Adiponectin and cancer: a systematic review. Br J Cancer 2006;94:1221-1225.